The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), ...

Myelodysplastic syndromes are diseases of older patients. The median age in the United States is 76 years old, meaning that most of your patients are going to be in their eighth decade of life, ...

Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients, ...

Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does ...

Some cancer treatments raise the risk of myelodysplastic syndromes. June 12, 2012— -- Jenna Langer was a high school senior when she was diagnosed with osteosarcoma, the most common form of ...

If you have MDS, a type of blood cancer called myelodysplastic syndrome, you’re part of a rare group of people with the diagnosis. But research is ongoing. Many clinical trials are seeking new ...

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

"Good Morning America" anchor Robert Roberts shared news today that she's facing a serious new health challenge: MDS or myelodysplastic syndrome. Dr. Richard Besser explains what MDS is and the ...

SAN DIEGO — Genetic mutations related to myelodysplastic syndrome occurred significantly more often among people who smoked than nonsmokers, according to study results presented at ASH Annual ...